832 WRF 3 (Jantoven 3 mg)
Generic Name: warfarin
Pill imprint 832 WRF 3 has been identified as Jantoven 3 mg.
Jantoven is used in the treatment of deep vein thrombosis, first event; prevention of thromboembolism in atrial fibrillation; pulmonary embolism, first event; deep vein thrombosis prophylaxis after hip replacement surgery; antiphospholipid syndrome (and more), and belongs to the drug class coumarins and indandiones. For women with mechanical heart valves: There is positive evidence of human fetal risk during pregnancy. For other pregnant populations: Not for use in pregnancy. Jantoven 3 mg is not subject to the Controlled Substances Act.
See also related documents.
Images for 832 WRF 3 (Jantoven 3 mg)
- Generic Name:
- 3 mg
- 9.00 mm
- Prescription only
- Drug Class:
- Coumarins and indandiones
- Pregnancy Category:
- D - Positive evidence of risk - for women with mechanical heart valves
X - Not for use in pregnancy - for other pregnant populations
- CSA Schedule:
- N - Not a controlled drug
- Upsher-Smith Laboratories, Inc
- National Drug Code (NDC):
- Inactive Ingredients:
- lactose monohydrate
|NDC Code||Manufacturer / Repackager|
|54868-5425||Physicians Total Care Inc (repackager)|
Note: Inactive ingredients may vary.
More about Jantoven (warfarin)
- Other brands: Coumadin